FAKTOR OPTIONSSCHEIN - ELANCO ANIMAL HEALTH Stock

Certificat

DE000PN2ELA0

Delayed Deutsche Boerse AG 10:05:11 2024-06-03 EDT
11.76 EUR +0.17% Intraday chart for FAKTOR OPTIONSSCHEIN - ELANCO ANIMAL HEALTH
1 month+67.24%
3 months+13.65%
Date Price Change
24-06-03 11.76 +0.17%
24-05-31 11.74 +1.91%
24-05-30 11.52 +0.35%
24-05-29 11.48 +4.46%
24-05-28 10.99 +4.57%

Delayed Quote Deutsche Boerse AG

Last update June 03, 2024 at 10:05 am

More quotes

Static data

Product typeProduits Exotiques
Buy / SellCALL
Underlying ELANCO ANIMAL HEALTH INCORPORATED
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN2ELA
ISINDE000PN2ELA0
Date issued 2022-01-21
Strike 17.68 $
Maturity Unlimited
Parity 1 : 1
Emission price 50
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 59.97
Lowest since issue 3.18
Spread 0.24
Spread %1.98%

Company Profile

Elanco Animal Health Incorporated is an animal health company. The Company is focused in delivering products and services to prevent and treat disease in farm animals and pets. Its portfolio serves animals across its core species consisting of dogs, cats and cattle, poultry, swine, sheep and aqua. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, poultry, and aquaculture. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.
Sector
-
More about the company

Ratings for Elanco Animal Health Incorporated

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Elanco Animal Health Incorporated

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
17.68 USD
Average target price
19.11 USD
Spread / Average Target
+8.11%
Consensus